ValuationViz

BEAM fund manager activity

Beam Therapeutics Inc · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q1 2021 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Stanley Druckenmiller - Duquesne Family OfficeNew153,600$5,272,0000.12%Aug 14, 2026
Joel Greenblatt - Gotham Asset ManagementNew10,720$367,9100.00%Aug 14, 2026

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Polen Capital ManagementSold out——0.00%Feb 12, 2026

Older quarters